Extension: Consultation on the Second Legislative Review of the Tobacco and Vaping Products Act

There is still time to share your input on the federal response to tobacco use in Canada!

Health Canada’s public consultation on the Tobacco and Vaping Products Act will inform the second legislative review of the Act and help shape the future of tobacco control in Canada.

The consultation has been extended in order to receive more of your valuable feedback, and is now open until November 17, 2023: https://www.canada.ca/en/health-canada/programs/consultation-second-legislative-review-tobacco-vaping-products-act.html

To assist in providing your input, a discussion paper was prepared that includes a list of key questions.

You may participate by sending your written submission to: legislativereviewtvpa.revisionlegislativeltpv@hc-sc.gc.ca

Legislative Review Secretariat
Tobacco Control Directorate
Controlled Substances and Cannabis Branch
Health Canada

Note: Canada is a Party to the World Health Organization Framework Convention on Tobacco Control. Article 5.3 of the Convention obliges parties, in setting and implementing their public health policies with respect to tobacco control, to protect these policies from commercial and other vested interests of the tobacco industry in accordance with national law. Therefore, the Government of Canada must actively exclude tobacco industry influence with respect to tobacco control policy. You must declare any perceived or actual conflicts of interest with the tobacco industry when providing input to this consultation. If you are part of the tobacco industry, an affiliated organization or an individual acting on their behalf, you must clearly state so in your submission.

We are also interested in being made aware of perceived or actual conflicts of interest with the vaping and/or pharmaceutical industry. As such, we request that you please declare this, if applicable, when providing your submission. If you are a member of the vaping and/or pharmaceutical industry, an affiliated organization or an individual acting on their behalf, you are asked to clearly indicate this in your submission.